UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 3, 2024
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
UTAH
|
|
| 87-0342734
|
(State or other jurisdiction of
|
|
| (IRS Employer
|
incorporation or organization)
|
|
| Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 3, 2024 at the Company’s annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration:
Elected Kevin L. Cornwell as a director of the Company:
For 1,436,389Withheld1,304,680Broker Non Votes 324,644
Elected Paul O. Richins as a director of the Company:
For907,483Withheld1,833,586Broker Non Votes 324,644
Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024:
For3,012,801Against49,443Abstentions 3,469
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
For2,662,106Against 72,899Abstentions 6,064 Broker Non Votes 324,644
Per Company policy, Mr. Richins tendered his resignation, which was conditioned upon acceptance by the Board of Directors. The Board of Directors voted not to accept his resignation. Per Utah law, Mr. Richins was elected to serve a three-year term and until his successor is elected and qualified.
The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials. Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
REGISTRANT
Date: 5/03/2024 By: /s/ Kevin L. Cornwell
Kevin L. Cornwell
Chairman & CEO